






















New studies assessing whether the p53 tumor 
suppressor influences lifespan in flies highlight the 
complexities inherent in modulating the activity of this 
potent and versatile transcriptional regulator.  
 
Promoting efficient regeneration while preventing 
cancer is critical for tissue homeostasis. Genes and 
processes that influence the balance between regenera-
tion and cancer are thus likely to affect lifespan of 
metazoans. Supporting this view, the tumor suppressor 
p53 has been found to strongly influence aging in mice. 
Interestingly, the lifespan consequences of increasing or 
decreasing p53 activity in mice are complex [1-5]. It is 
no surprise that loss of p53 leads to increased cancer 
incidence, and thus shorter lifespan [2]. Yet increasing 
p53 activity can have pleiotropic consequences: such 
interventions generally prevent cancer, increasing 
lifespan in some cases, but can also cause accelerated 
aging in others [6-11]. The discrepancy between life-
span shortening and lifespan extending consequences of 
p53 gain-of-function conditions has been attributed to 
differences in regulation of the corresponding 
transgenes, and highlights the complex and dose-
dependent effects that such a versatile regulator of cell 
proliferation, repair and death can have on health span 
and aging [2]. The exact reasons for the pleiotropic 
effects of p53 on aging, however, remain elusive. 
 
Aging studies in less complex model organisms might 

























puzzle. New studies by the Tower and Helfand labs   
assess the consequences of modulating p53 activity for 
the lifespan of flies, and shed light on the complexities 
of p53 function in even such relatively simple 
organisms [12-15].  
 
In an exhaustive analysis of the lifespan effects of p53 
gain- and loss-of-function conditions, Waskar and 
colleagues find strikingly pleiotropic effects resulting 
from ubiquitous increase or decrease of wild type p53 
function [12]. Importantly, the consequences of 
modulating p53 are found to be tissue-, stage- and sex-
specific: ubiquitous over-expression of p53 in adults 
shortens lifespan in females but slightly increases 
lifespan in males [12], whereas neuronal expression of 
the same construct extends lifespan in females and 
decreases life span in males [13]. Over-expressing p53 
in larval stages, on the other hand, is sufficient to extend 
adult lifespan in both sexes, but in a dose-dependent 
manner, where strong expression is deleterious for 
lifespan, while moderate to weak over-expression 
increases lifespan [12].  
 
The authors further examine the lifespan of a battery of 
mutants in which the endogenous p53 gene is disrupted, 
and find robust increase of lifespan in females, but 
context-dependent effects in males [12]. Confirming 
earlier studies by the Helfand lab, which demonstrated 
lifespan extension when dominant-negative p53 is 
expressed in neurons [16-18], Waskar and colleagues 
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form of p53 extends lifespan moderately in females [12].  
The pleiotropic and sex-specific effects of modulating 
p53 activity in adults are likely caused by specific 
functions of this tumor suppressor in particular bio-
logical processes. It is tempting to speculate that p53 
might act to compromise or maintain the function of 
various tissues and processes in specific ways, thus 
causing antagonistic effects on overall lifespan. For 
example, (i) p53 is expressed in the female germline 
[19, 20], and modulating p53 expression in this tissue is 
likely to affect its function. The ablation of germline 
stem cells has recently been shown to cause robust 
lifespan extension in Drosophila [21], suggesting that 
the effects of ubiquitous over-expression of p53 might 
in part be mediated by p53 function in this tissue.  
(ii) expression of p53 in intestinal stem cells (ISCs) 
leads to cell loss and strongly impairs gut regeneration 
[22]. Interestingly, probably due to a higher nutrient 
demand, intestinal tissue turnover is faster in females 
than in males [22]. As a consequence, p53-induced loss 
of ISCs would negatively affect female lifespan 
preferentially, counteracting the beneficial effects of 
neuronal expression or reduced germline function.     
(iii) the regulation of insulin-like peptide production by 
p53 (described by [16] is likely to influence tissue 
function systemically and thus further complicate the 
effects of p53 on lifespan. Accordingly, Foxo modulates 
the sex-specific lifespan consequences of p53 over-
expression [13].  
(iv) the lifespan extending effects of a dominant mutant 
p53 transgene were not additive with Sir2 over-
expression or dietary restriction (DR) [14, 15], and the 
life span extension due to wild-type p53 over-
expression was dependent upon Sir2 function [13], 
indicating that tissue-specific interactions between these 
proteins might control metabolic homeostasis, further 
complicating the lifespan effects of modulating p53 
activity. 
 
The fly offers unique tools to start testing these 
hypotheses, and it can thus be expected that the tissue-
specific functions of p53, and the relative contribution 
of these functions to overall lifespan will be further 
explored in the near future.  Such studies are expected 
to help obtaining a comprehensive view of the effects of 
p53 on tissue homeostasis, metabolic control, and other 
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